FTC said unlikely to be able to challenge Amazon's planned One Medical purchase
georgeclerk


The Federal Trade Commission is said unlikely to challenge Amazon's (NASDAQ:AMZN) planned acquisition of One Medical (NASDAQ:ONEM) as there don't appear to be any business overlaps or vertical issues.
The only issue the antitrust regulator may have is Amazon's (AMZN) size, though the FTC likely won't have any real theory to stop a transaction, according to a Dealreporter item earlier, which cited sources familiar.

One source said the deal is like Amazon's recent purchase of MGM, which the FTC didn't like, but there was nothing it could really do about the deal, Dealreporter said.
Amazon (AMZN) agreed to purchase One Medical (ONEM), an operator of a membership-based primary care platform for nearly $3.9B, the companies announced on Thursday.